{"name":"OrbiMed Advisors","permalink":"orbimed-advisors","crunchbase_url":"http://www.crunchbase.com/financial-organization/orbimed-advisors","homepage_url":"http://www.orbimed.com/","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"1-212-739-6400","description":"","email_address":"info@orbimed.com","number_of_employees":null,"founded_year":1989,"founded_month":null,"founded_day":null,"tag_list":"","alias_list":"","created_at":"Mon Apr 13 20:57:01 UTC 2009","updated_at":"Wed Jun 24 22:49:43 UTC 2009","overview":"<p>OrbiMed is ahealthcare-dedicated investment firm, with approximately $5 billion in assets under management. OrbiMed&#8217;s investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies. OrbiMed manages the Caduceus Private Investments series of venture capital funds and a family of public equity investment funds.</p>","image":{"available_sizes":[[[150,42],"assets/images/resized/0005/0248/50248v1-max-150x150.png"],[[203,58],"assets/images/resized/0005/0248/50248v1-max-250x250.png"],[[203,58],"assets/images/resized/0005/0248/50248v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"767 Third Avenue","address2":"30th Floor","zip_code":"10017","city":"New York","state_code":"NY","country_code":"USA","latitude":40.754216,"longitude":-73.971535}],"relationships":[{"is_past":false,"title":"Chief Financial Officer","person":{"first_name":"Eric","last_name":"Bittelman","permalink":"eric-bittelman","image":{"available_sizes":[[[82,95],"assets/images/resized/0005/0249/50249v1-max-150x150.jpg"],[[82,95],"assets/images/resized/0005/0249/50249v1-max-250x250.jpg"],[[82,95],"assets/images/resized/0005/0249/50249v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Controller","person":{"first_name":"Donald","last_name":"Bennett","permalink":"donald-bennett","image":{"available_sizes":[[[82,95],"assets/images/resized/0005/0250/50250v1-max-150x150.jpg"],[[82,95],"assets/images/resized/0005/0250/50250v1-max-250x250.jpg"],[[82,95],"assets/images/resized/0005/0250/50250v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Venture Partner","person":{"first_name":"Dr","last_name":"Peter Thompson","permalink":"dr-peter-thompson","image":null}},{"is_past":false,"title":"Venture Partner","person":{"first_name":"Vince","last_name":"Burgess","permalink":"vince-burgess","image":null}},{"is_past":false,"title":"Venture Partner","person":{"first_name":"Joseph","last_name":"Zakrewski","permalink":"joseph-zakrewski","image":null}}],"investments":[{"funding_round":{"round_code":"b","source_url":"http://www.devicespace.com/news_story.aspx?StoryId=133375","source_description":"CeraPedics, Inc. Raises $15 Million","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":4,"funded_day":2,"company":{"name":"Cerapedics","permalink":"cerapedics","image":{"available_sizes":[[[150,46],"assets/images/resized/0004/1066/41066v1-max-150x150.png"],[[250,77],"assets/images/resized/0004/1066/41066v1-max-250x250.png"],[[251,78],"assets/images/resized/0004/1066/41066v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.xconomy.com/boston/2009/01/27/innovative-spinal-technologies-jilted-now-bankrupt-source-says/","source_description":"Innovative Spinal Technologies Jilted, Now Bankrupt, Source Says","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":9,"funded_day":8,"company":{"name":"Innovative Spinal Technologies","permalink":"innovative-spinal-technologies","image":null}}},{"funding_round":{"round_code":"e","source_url":"http://www.bio-medicine.org/biology-technology-1/Singulex-Closes--2419-Million-Financing-Round-9897-1/","source_description":"Singulex Closes $19 Million Financing Round","raised_amount":19000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":1,"funded_day":12,"company":{"name":"Singulex","permalink":"singulex","image":{"available_sizes":[[[150,52],"assets/images/resized/0004/8380/48380v1-max-150x150.jpg"],[[250,87],"assets/images/resized/0004/8380/48380v1-max-250x250.jpg"],[[290,101],"assets/images/resized/0004/8380/48380v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/aragon-pharmaceuticals-inc-series-a-8m/","source_description":"Aragon Pharmaceuticals, Inc.: Series A $8M","raised_amount":8000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":5,"funded_day":27,"company":{"name":"Aragon Pharmaceuticals","permalink":"aragon-pharmaceuticals","image":{"available_sizes":[[[150,43],"assets/images/resized/0004/9225/49225v2-max-150x150.jpg"],[[226,66],"assets/images/resized/0004/9225/49225v2-max-250x250.jpg"],[[226,66],"assets/images/resized/0004/9225/49225v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://venturebeat.com/2007/06/07/biomarker-diagnostics-developer-singulex-validates-19m/","source_description":"Biomarker-diagnostics developer Singulex validates $19M","raised_amount":19000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":6,"funded_day":7,"company":{"name":"Singulex","permalink":"singulex","image":{"available_sizes":[[[150,52],"assets/images/resized/0004/8380/48380v1-max-150x150.jpg"],[[250,87],"assets/images/resized/0004/8380/48380v1-max-250x250.jpg"],[[290,101],"assets/images/resized/0004/8380/48380v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.mitsuiventures.com/en/investment/news/2008/20081006.html","source_description":"Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of LocteronÂ® in Hepatitis C","raised_amount":60000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":10,"funded_day":6,"company":{"name":"Biolex Therapeutics","permalink":"biolex-therapeutics","image":{"available_sizes":[[[150,50],"assets/images/resized/0005/0190/50190v1-max-150x150.png"],[[250,84],"assets/images/resized/0005/0190/50190v1-max-250x250.png"],[[263,89],"assets/images/resized/0005/0190/50190v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.equityhelpdesk.com/PrivateEquity/Glaukos_Adds_35_Million","source_description":"Glaukos Adds $35 Million","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":8,"funded_day":29,"company":{"name":"Glaukos","permalink":"glaukos","image":{"available_sizes":[[[135,22],"assets/images/resized/0005/0243/50243v1-max-150x150.png"],[[135,22],"assets/images/resized/0005/0243/50243v1-max-250x250.png"],[[135,22],"assets/images/resized/0005/0243/50243v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://deals.venturebeat.com/2008/08/04/interkrin-raises-185-for-continued-work-on-diabetes-drug/","source_description":"InteKrin raises $18.5M for continued work on diabetes drug","raised_amount":18500000,"raised_currency_code":"USD","funded_year":2008,"funded_month":8,"funded_day":4,"company":{"name":"InteKrin","permalink":"interkrin","image":{"available_sizes":[[[150,42],"assets/images/resized/0005/0799/50799v1-max-150x150.png"],[[184,52],"assets/images/resized/0005/0799/50799v1-max-250x250.png"],[[184,52],"assets/images/resized/0005/0799/50799v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://investors.aryx.com/releasedetail.cfm?ReleaseID=347282","source_description":"ARYx Therapeutics Inc. Announces $21.6 Million Private Placement","raised_amount":21600000,"raised_currency_code":"USD","funded_year":2008,"funded_month":11,"funded_day":12,"company":{"name":"ARYx Therapeutics","permalink":"aryx-therapeutics","image":{"available_sizes":[[[150,61],"assets/images/resized/0005/2970/52970v1-max-150x150.jpg"],[[199,81],"assets/images/resized/0005/2970/52970v1-max-250x250.jpg"],[[199,81],"assets/images/resized/0005/2970/52970v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.chemocentryx.com/news/2004/pr20040617.pdf","source_description":"ChemoCentryx Raises $33 Million in Private Financing","raised_amount":33000000,"raised_currency_code":"USD","funded_year":2004,"funded_month":6,"funded_day":17,"company":{"name":"ChemoCentryx","permalink":"chemocentryx","image":{"available_sizes":[[[127,77],"assets/images/resized/0005/4088/54088v1-max-150x150.jpg"],[[127,77],"assets/images/resized/0005/4088/54088v1-max-250x250.jpg"],[[127,77],"assets/images/resized/0005/4088/54088v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.fiercebiotech.com/story/complete-genomics-bags-45m-round-sequencing/2009-08-24?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0","source_description":"Complete Genomics bags $45M round for sequencing","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":8,"funded_day":24,"company":{"name":"Complete Genomics","permalink":"complete-genomics","image":{"available_sizes":[[[150,43],"assets/images/resized/0005/7515/57515v2-max-150x150.png"],[[250,72],"assets/images/resized/0005/7515/57515v2-max-250x250.png"],[[289,84],"assets/images/resized/0005/7515/57515v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://deals.venturebeat.com/2007/04/18/sientra-device-maker-for-plastic-surgery-raises-85m/","source_description":"Sientra, device maker for plastic surgery, raises $85M","raised_amount":85000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":4,"funded_day":18,"company":{"name":"Sientra","permalink":"sientra","image":{"available_sizes":[[[150,63],"assets/images/resized/0005/9574/59574v1-max-150x150.png"],[[165,70],"assets/images/resized/0005/9574/59574v1-max-250x250.png"],[[165,70],"assets/images/resized/0005/9574/59574v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://deals.venturebeat.com/2007/03/22/chemocentryx-autoimmune-disease-drug-co-raises-2984m/","source_description":"ChemoCentryx, autoimmune disease drug co., raises $29.84M","raised_amount":29840000,"raised_currency_code":"USD","funded_year":2007,"funded_month":3,"funded_day":22,"company":{"name":"ChemoCentryx","permalink":"chemocentryx","image":{"available_sizes":[[[127,77],"assets/images/resized/0005/4088/54088v1-max-150x150.jpg"],[[127,77],"assets/images/resized/0005/4088/54088v1-max-250x250.jpg"],[[127,77],"assets/images/resized/0005/4088/54088v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.enobia.com/press_releases-30.html","source_description":"Enobia Raises US$50M from Current Investors in Series C Financing ","raised_amount":50000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":8,"funded_day":10,"company":{"name":"Enobia Pharma","permalink":"enobia-pharma","image":{"available_sizes":[[[150,145],"assets/images/resized/0006/0774/60774v1-max-150x150.png"],[[153,148],"assets/images/resized/0006/0774/60774v1-max-250x250.png"],[[153,148],"assets/images/resized/0006/0774/60774v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.enobia.com/press_releases-30.html","source_description":"","raised_amount":40100000,"raised_currency_code":"CAD","funded_year":2007,"funded_month":8,"funded_day":1,"company":{"name":"Enobia Pharma","permalink":"enobia-pharma","image":{"available_sizes":[[[150,145],"assets/images/resized/0006/0774/60774v1-max-150x150.png"],[[153,148],"assets/images/resized/0006/0774/60774v1-max-250x250.png"],[[153,148],"assets/images/resized/0006/0774/60774v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.bio-medicine.org/biology-technology-1/PharmAbcine-Closes-USD--246-Million-Series-A-Financing-14102-1/","source_description":"PharmAbcine Closes USD $6 Million Series A Financing","raised_amount":6000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":9,"funded_day":16,"company":{"name":"PharmAbcine","permalink":"pharmabcine","image":{"available_sizes":[[[150,35],"assets/images/resized/0006/1120/61120v1-max-150x150.png"],[[182,43],"assets/images/resized/0006/1120/61120v1-max-250x250.png"],[[182,43],"assets/images/resized/0006/1120/61120v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32&aid=DJFVW00020091202e5c3000gp&r=Rss&s=DJFVW","source_description":"OrbiMed Makes First Indian Investment Through Pan Asia Fund ","raised_amount":null,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":2,"company":{"name":"Manipal Acunova","permalink":"manipal-acunova","image":{"available_sizes":[[[150,24],"assets/images/resized/0006/8358/68358v1-max-150x150.jpg"],[[237,39],"assets/images/resized/0006/8358/68358v1-max-250x250.jpg"],[[237,39],"assets/images/resized/0006/8358/68358v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/adimab-inc-series-d-82m/","source_description":"Adimab, Inc.: Series D $8.2M","raised_amount":8200000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":22,"company":{"name":"Adimab","permalink":"adimab","image":{"available_sizes":[[[150,80],"assets/images/resized/0007/4523/74523v1-max-150x150.jpg"],[[206,110],"assets/images/resized/0007/4523/74523v1-max-250x250.jpg"],[[206,110],"assets/images/resized/0007/4523/74523v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.adimab.com/adimab_pr_11_20_08.pdf","source_description":"Adimab, Inc. Announces Series C Financing","raised_amount":4000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":11,"funded_day":20,"company":{"name":"Adimab","permalink":"adimab","image":{"available_sizes":[[[150,80],"assets/images/resized/0007/4523/74523v1-max-150x150.jpg"],[[206,110],"assets/images/resized/0007/4523/74523v1-max-250x250.jpg"],[[206,110],"assets/images/resized/0007/4523/74523v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.agensys.com/pressrelease_071207.html","source_description":"Agensys Raises $41 Million","raised_amount":41300000,"raised_currency_code":"USD","funded_year":2007,"funded_month":7,"funded_day":12,"company":{"name":"Agensys","permalink":"agensys","image":{"available_sizes":[[[149,65],"assets/images/resized/0007/9921/79921v1-max-150x150.jpg"],[[149,65],"assets/images/resized/0007/9921/79921v1-max-250x250.jpg"],[[149,65],"assets/images/resized/0007/9921/79921v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.thefreelibrary.com/SGX+Pharmaceuticals+raises+$25+million:+SGX+Pharmaceuticals+Inc-a0172776208","source_description":"SGX Pharmaceuticals raises $25 million: SGX Pharmaceuticals Inc.","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":11,"funded_day":20,"company":{"name":"SGX Pharmaceuticals","permalink":"sgx-pharmaceuticals","image":null}}},{"funding_round":{"round_code":"unattributed","source_url":"http://rnaventures.blogspot.com/2007/02/cerapedics-closes-1225m-pe-financing.html","source_description":"CeraPedics Closes $12.25M PE Financing","raised_amount":12250000,"raised_currency_code":"USD","funded_year":2007,"funded_month":2,"funded_day":28,"company":{"name":"Cerapedics","permalink":"cerapedics","image":{"available_sizes":[[[150,46],"assets/images/resized/0004/1066/41066v1-max-150x150.png"],[[250,77],"assets/images/resized/0004/1066/41066v1-max-250x250.png"],[[251,78],"assets/images/resized/0004/1066/41066v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":9100000,"raised_currency_code":"USD","funded_year":2007,"funded_month":6,"funded_day":28,"company":{"name":"EUSA Pharma","permalink":"eusa-pharma","image":{"available_sizes":[[[150,33],"assets/images/resized/0005/9049/59049v2-max-150x150.png"],[[250,55],"assets/images/resized/0005/9049/59049v2-max-250x250.png"],[[263,58],"assets/images/resized/0005/9049/59049v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.freshnews.com/news/306332/selecta-closes-15-million-series-c-financing","source_description":"SELECTA CLOSES $15 MILLION SERIES C FINANCING  ","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":5,"company":{"name":"Selecta Biosciences","permalink":"selecta-biosciences","image":{"available_sizes":[[[150,46],"assets/images/resized/0004/1146/41146v1-max-150x150.png"],[[245,76],"assets/images/resized/0004/1146/41146v1-max-250x250.png"],[[245,76],"assets/images/resized/0004/1146/41146v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://macrogenics.com/press_releases-244.html","source_description":"MacroGenics Raises $45M in Series C Financing - Company to Advance Monoclonal Antibody Clinical Programs","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":5,"funded_day":17,"company":{"name":"MacroGenics","permalink":"macrogenics","image":{"available_sizes":[[[150,95],"assets/images/resized/0005/9708/59708v1-max-150x150.jpg"],[[188,120],"assets/images/resized/0005/9708/59708v1-max-250x250.jpg"],[[188,120],"assets/images/resized/0005/9708/59708v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.acceleronpharma.com/content/news/press-releases/detail.jsp/q/news-id/18","source_description":"Acceleron Pharma Closes $30M Series B Financing","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":8,"funded_day":2,"company":{"name":"Acceleron Pharma","permalink":"acceleron-pharma","image":{"available_sizes":[[[150,82],"assets/images/resized/0006/9823/69823v1-max-150x150.png"],[[233,128],"assets/images/resized/0006/9823/69823v1-max-250x250.png"],[[233,128],"assets/images/resized/0006/9823/69823v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://business.highbeam.com/1758/article-1G1-142700597/arius-closes-us-million-financing","source_description":"ARIUS Closes US$21.5 Million Financing","raised_amount":21500000,"raised_currency_code":"USD","funded_year":2006,"funded_month":3,"funded_day":1,"company":{"name":"Arius Research","permalink":"arius-research","image":null}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":18600000,"raised_currency_code":"USD","funded_year":2006,"funded_month":11,"funded_day":7,"company":{"name":"EUSA Pharma","permalink":"eusa-pharma","image":{"available_sizes":[[[150,33],"assets/images/resized/0005/9049/59049v2-max-150x150.png"],[[250,55],"assets/images/resized/0005/9049/59049v2-max-250x250.png"],[[263,58],"assets/images/resized/0005/9049/59049v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://chemocentryx.com/news/2006/pr20060824b.html","source_description":"ChemoCentryx Completes Series C Financing","raised_amount":17700000,"raised_currency_code":"USD","funded_year":2006,"funded_month":8,"funded_day":24,"company":{"name":"ChemoCentryx","permalink":"chemocentryx","image":{"available_sizes":[[[127,77],"assets/images/resized/0005/4088/54088v1-max-150x150.jpg"],[[127,77],"assets/images/resized/0005/4088/54088v1-max-250x250.jpg"],[[127,77],"assets/images/resized/0005/4088/54088v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/aragon-pharma-readies-first-cancer-trial-after-22m-b-round/2010-04-22","source_description":"Aragon Pharma readies first cancer trial after $22M B round ","raised_amount":22000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":22,"company":{"name":"Aragon Pharmaceuticals","permalink":"aragon-pharmaceuticals","image":{"available_sizes":[[[150,43],"assets/images/resized/0004/9225/49225v2-max-150x150.jpg"],[[226,66],"assets/images/resized/0004/9225/49225v2-max-250x250.jpg"],[[226,66],"assets/images/resized/0004/9225/49225v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/igenica-inc-series-b-24m/","source_description":"Igenica, Inc.: Series B $24M","raised_amount":24000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":14,"company":{"name":"Igenica","permalink":"igenica","image":{"available_sizes":[[[150,65],"assets/images/resized/0009/0611/90611v1-max-150x150.jpg"],[[250,109],"assets/images/resized/0009/0611/90611v1-max-250x250.jpg"],[[265,116],"assets/images/resized/0009/0611/90611v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.allbusiness.com/banking-finance/financial-markets-investing-funds/5047060-1.html","source_description":"Adiana, Inc. Reports Completion of $23 Million Financing.","raised_amount":23000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":8,"funded_day":25,"company":{"name":"Adiana","permalink":"adiana","image":{"available_sizes":[[[150,60],"assets/images/resized/0006/0308/60308v1-max-150x150.png"],[[214,87],"assets/images/resized/0006/0308/60308v1-max-250x250.png"],[[214,87],"assets/images/resized/0006/0308/60308v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":13970000,"raised_currency_code":"USD","funded_year":2005,"funded_month":7,"funded_day":19,"company":{"name":"EUSA Pharma","permalink":"eusa-pharma","image":{"available_sizes":[[[150,33],"assets/images/resized/0005/9049/59049v2-max-150x150.png"],[[250,55],"assets/images/resized/0005/9049/59049v2-max-250x250.png"],[[263,58],"assets/images/resized/0005/9049/59049v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.masshightech.com/stories/2010/06/21/daily19-Acceleron-Pharma-pulls-in-84M-financing.html","source_description":"Acceleron Pharma pulls in $8.4M financing","raised_amount":8400000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":22,"company":{"name":"Acceleron Pharma","permalink":"acceleron-pharma","image":{"available_sizes":[[[150,82],"assets/images/resized/0006/9823/69823v1-max-150x150.png"],[[233,128],"assets/images/resized/0006/9823/69823v1-max-250x250.png"],[[233,128],"assets/images/resized/0006/9823/69823v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://deals.venturebeat.com/2010/07/15/dfine-raises-36-2m-to-repair-spine-fractures/","source_description":"DFine raises $36.2M to repair spine fractures","raised_amount":36200000,"raised_currency_code":"USD","funded_year":2010,"funded_month":7,"funded_day":15,"company":{"name":"DFine","permalink":"dfine-inc","image":{"available_sizes":[[[150,36],"assets/images/resized/0003/4206/34206v2-max-150x150.jpg"],[[195,47],"assets/images/resized/0003/4206/34206v2-max-250x250.jpg"],[[195,47],"assets/images/resized/0003/4206/34206v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.cerenis.com/media-detail.asp?id=253","source_description":"Cerenis Therapeutics raises EUR 40 million in series C financing","raised_amount":40000000,"raised_currency_code":"EUR","funded_year":2010,"funded_month":7,"funded_day":26,"company":{"name":"Cerenis Therapeutics","permalink":"cerenis-therapeutics","image":{"available_sizes":[[[150,64],"assets/images/resized/0010/6866/106866v1-max-150x150.png"],[[191,82],"assets/images/resized/0010/6866/106866v1-max-250x250.png"],[[191,82],"assets/images/resized/0010/6866/106866v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://www.completegenomics.com/news-events/press-releases/Complete-Genomics-Inc-Announces-Completion-of-39-Million--Series-E-Financing-and-Addresses-Illumina-Patent-Infringement-Lawsuit-101026744.html","source_description":"Complete Genomics, Inc. Announces Completion of $39 Million Series E Financing ","raised_amount":39000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":19,"company":{"name":"Complete Genomics","permalink":"complete-genomics","image":{"available_sizes":[[[150,43],"assets/images/resized/0005/7515/57515v2-max-150x150.png"],[[250,72],"assets/images/resized/0005/7515/57515v2-max-250x250.png"],[[289,84],"assets/images/resized/0005/7515/57515v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.viewray.com/news/ViewRay_SeriesCfunding_25Aug2010.pdf","source_description":"ViewRay Secures Series C Financing","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":25,"company":{"name":"ViewRay","permalink":"viewray","image":null}}},{"funding_round":{"round_code":"a","source_url":"http://www.goodstartgenetics.com/images/PressReleases/goodstartgeneticspressrelease09102010.pdf","source_description":"Good Start Genetics, Inc. Raises $18 Million to Develop and Launch Sequencingâ€Based Preâ€Pregnancy Genetic Screening Test","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":10,"company":{"name":"Good Start Genetics","permalink":"good-start-genetics","image":{"available_sizes":[[[107,75],"assets/images/resized/0010/1463/101463v1-max-150x150.png"],[[107,75],"assets/images/resized/0010/1463/101463v1-max-250x250.png"],[[107,75],"assets/images/resized/0010/1463/101463v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.integraventures.net/news.htm#amnis","source_description":"Amnis Closes Oversubscribed $11.25M Series C Round ","raised_amount":11250000,"raised_currency_code":"USD","funded_year":2005,"funded_month":8,"funded_day":29,"company":{"name":"Amnis","permalink":"amnis","image":{"available_sizes":[[[120,70],"assets/images/resized/0010/1616/101616v1-max-150x150.png"],[[120,70],"assets/images/resized/0010/1616/101616v1-max-250x250.png"],[[120,70],"assets/images/resized/0010/1616/101616v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2010/09/relypsa-raises-70m-in-series-b.html","source_description":"Relypsa Raises $70M in Series B Financing","raised_amount":70000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":13,"company":{"name":"Relypsa","permalink":"relypsa","image":{"available_sizes":[[[150,79],"assets/images/resized/0003/7781/37781v1-max-150x150.png"],[[250,132],"assets/images/resized/0003/7781/37781v1-max-250x250.png"],[[292,155],"assets/images/resized/0003/7781/37781v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2010/09/eddingpharm-cayman-closes-24m-series-b.html","source_description":"Eddingpharm (Cayman) Closes $24M Series B Funding","raised_amount":24000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":17,"company":{"name":"Eddingpharm (Cayman)","permalink":"eddingpharm-cayman","image":{"available_sizes":[[[150,70],"assets/images/resized/0010/3680/103680v1-max-150x150.png"],[[177,83],"assets/images/resized/0010/3680/103680v1-max-250x250.png"],[[177,83],"assets/images/resized/0010/3680/103680v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.superdimension.com/view/files/PressRelease/superDimension_Financing_Release%20%209-7-2010.pdf","source_description":"superDimension Raises $24.8 Million in Debt and Equity Financing","raised_amount":24800000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":7,"company":{"name":"SuperDimension","permalink":"superdimension","image":{"available_sizes":[[[150,34],"assets/images/resized/0010/7341/107341v2-max-150x150.jpg"],[[181,42],"assets/images/resized/0010/7341/107341v2-max-250x250.jpg"],[[181,42],"assets/images/resized/0010/7341/107341v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://investor.anthera.com/releasedetail.cfm?ReleaseID=509533","source_description":"Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing","raised_amount":31500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":21,"company":{"name":"Anthera Pharmaceuticals","permalink":"anthera-pharmaceuticals","image":{"available_sizes":[[[150,43],"assets/images/resized/0007/7869/77869v1-max-150x150.png"],[[212,61],"assets/images/resized/0007/7869/77869v1-max-250x250.png"],[[212,61],"assets/images/resized/0007/7869/77869v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.bonovo-ortho.com/cmsfiles/Press/Series-C-Financing.pdf","source_description":"Bonovo Orthopedics, Inc. Closes Series C Financing Led by OrbiMed Asia Partners","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":12,"funded_day":23,"company":{"name":"Bonovo Orthopedics","permalink":"bonovo-orthopedics","image":{"available_sizes":[[[150,75],"assets/images/resized/0011/5273/115273v1-max-150x150.jpg"],[[228,115],"assets/images/resized/0011/5273/115273v1-max-250x250.jpg"],[[228,115],"assets/images/resized/0011/5273/115273v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.news-medical.net/news/20110228/Arsanis-closes-Series-A-financing-for-2410-million.aspx","source_description":"Arsanis closes Series A financing for $10 million","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":2,"funded_day":28,"company":{"name":"Arsanis","permalink":"arsanis","image":{"available_sizes":[[[150,49],"assets/images/resized/0012/4388/124388v1-max-150x150.png"],[[248,82],"assets/images/resized/0012/4388/124388v1-max-250x250.png"],[[248,82],"assets/images/resized/0012/4388/124388v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.globes.co.il/serveen/globes/docview.asp?did=1000635647&fid=1725","source_description":"Brain clot protection co SMT raises $10.5m","raised_amount":10500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":4,"funded_day":3,"company":{"name":"SMT Research and Development","permalink":"smt-research-and-development","image":{"available_sizes":[[[150,26],"assets/images/resized/0012/9414/129414v1-max-150x150.png"],[[226,40],"assets/images/resized/0012/9414/129414v1-max-250x250.png"],[[226,40],"assets/images/resized/0012/9414/129414v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.equityhelpdesk.com/finance-news/crown-bioscience-closes-288m-series-c-financing-round","source_description":"Crown Bioscience Closes $28.8M Series C Financing Round","raised_amount":28800000,"raised_currency_code":"USD","funded_year":2011,"funded_month":5,"funded_day":4,"company":{"name":"Crown Bioscience","permalink":"crown-bioscience","image":{"available_sizes":[[[150,67],"assets/images/resized/0013/3198/133198v1-max-150x150.jpg"],[[227,102],"assets/images/resized/0013/3198/133198v1-max-250x250.jpg"],[[227,102],"assets/images/resized/0013/3198/133198v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.masshightech.com/stories/2011/05/09/daily48-Connecticuts-Biodel-plans-to-raise-30M.html","source_description":"Connecticutâ€™s Biodel plans to raise $30M","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":5,"funded_day":13,"company":{"name":"Biodel","permalink":"biodel","image":{"available_sizes":[[[150,48],"assets/images/resized/0013/4596/134596v1-max-150x150.png"],[[204,66],"assets/images/resized/0013/4596/134596v1-max-250x250.png"],[[204,66],"assets/images/resized/0013/4596/134596v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.ambitbio.com/news/press_061011.htm","source_description":"AMBIT BIOSCIENCES COMPLETES $30 MILLION SERIES D-2 FINANCING","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":10,"company":{"name":"Ambit Biosciences","permalink":"ambit-biosciences","image":{"available_sizes":[[[95,108],"assets/images/resized/0013/8681/138681v1-max-150x150.png"],[[95,108],"assets/images/resized/0013/8681/138681v1-max-250x250.png"],[[95,108],"assets/images/resized/0013/8681/138681v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2011/07/roka-bioscience-completes-20m-series-equity-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Roka Bioscience Completes $20M Series C Equity Financing","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":7,"funded_day":28,"company":{"name":"Roka Bioscience","permalink":"roka-bioscience","image":{"available_sizes":[[[150,77],"assets/images/resized/0014/6799/146799v1-max-150x150.jpg"],[[222,114],"assets/images/resized/0014/6799/146799v1-max-250x250.jpg"],[[222,114],"assets/images/resized/0014/6799/146799v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2011/08/vessix-vascular-completes-23m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Vessix Vascular Completes $23M Series B Financing","raised_amount":23000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":3,"company":{"name":"Vessix Vascular","permalink":"vessix-vascular","image":{"available_sizes":[[[150,95],"assets/images/resized/0010/6504/106504v2-max-150x150.jpg"],[[250,159],"assets/images/resized/0010/6504/106504v2-max-250x250.jpg"],[[450,287],"assets/images/resized/0010/6504/106504v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://wraltechwire.com/business/tech_wire/medcity/story/10066279/","source_description":"MRI-guided radiotherapy firm ViewRay gets $10M in new funding","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":9,"funded_day":2,"company":{"name":"ViewRay","permalink":"viewray","image":null}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/10/cleave-biosciences-raises-42m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Cleave Biosciences Raises $42M in Series A Financing","raised_amount":42000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":10,"funded_day":11,"company":{"name":"Cleave Biosciences","permalink":"cleave-biosciences","image":null}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2011/10/arteaus-therapeutics-raises-18m-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Arteaus Therapeutics Raises $18M in Funding","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":10,"funded_day":19,"company":{"name":"Arteaus Therapeutics","permalink":"arteaus-therapeutics","image":{"available_sizes":[[[120,60],"assets/images/resized/0015/8790/158790v1-max-150x150.jpg"],[[120,60],"assets/images/resized/0015/8790/158790v1-max-250x250.jpg"],[[120,60],"assets/images/resized/0015/8790/158790v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2011/11/dfine-closes-25m-equity-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"DFINE Closes $25M Equity Financing","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":11,"funded_day":8,"company":{"name":"DFine","permalink":"dfine-inc","image":{"available_sizes":[[[150,36],"assets/images/resized/0003/4206/34206v2-max-150x150.jpg"],[[195,47],"assets/images/resized/0003/4206/34206v2-max-250x250.jpg"],[[195,47],"assets/images/resized/0003/4206/34206v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.rempexpharma.com/news/11-9-11","source_description":"Rempex Announces Series B Financing of up to $67.5 Million","raised_amount":67500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":11,"funded_day":9,"company":{"name":"Rempex Pharmaceuticals","permalink":"rempex-pharmaceuticals","image":{"available_sizes":[[[150,33],"assets/images/resized/0016/1699/161699v1-max-150x150.png"],[[250,55],"assets/images/resized/0016/1699/161699v1-max-250x250.png"],[[276,61],"assets/images/resized/0016/1699/161699v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2011/12/argen-x-closes-e27-5m-series-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"arGEN-X Closes â‚¬27.5M Series B Funding Round","raised_amount":27500000,"raised_currency_code":"EUR","funded_year":2011,"funded_month":12,"funded_day":1,"company":{"name":"arGEN-X","permalink":"argen-x","image":{"available_sizes":[[[137,56],"assets/images/resized/0005/9706/59706v1-max-150x150.png"],[[137,56],"assets/images/resized/0005/9706/59706v1-max-250x250.png"],[[137,56],"assets/images/resized/0005/9706/59706v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.prnewswire.com/news-releases/roka-bioscience-secures-475-million-in-series-d-financing-136829263.html","source_description":"Roka Bioscience Secures $47.5 Million in Series D Financing","raised_amount":47500000,"raised_currency_code":"USD","funded_year":2012,"funded_month":1,"funded_day":8,"company":{"name":"Roka Bioscience","permalink":"roka-bioscience","image":{"available_sizes":[[[150,77],"assets/images/resized/0014/6799/146799v1-max-150x150.jpg"],[[222,114],"assets/images/resized/0014/6799/146799v1-max-250x250.jpg"],[[222,114],"assets/images/resized/0014/6799/146799v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2012/03/viewray-closes-45m-series-venture-capital-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"ViewRay Closes $45M Series C Venture Capital Financing","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":3,"funded_day":13,"company":{"name":"ViewRay","permalink":"viewray","image":null}}},{"funding_round":{"round_code":"b","source_url":"http://www.masshightech.com/stories/2012/04/02/daily6-Good-Start-Genetics-lands-14M.html","source_description":"Good Start Genetics lands $14M","raised_amount":14000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":4,"funded_day":2,"company":{"name":"Good Start Genetics","permalink":"good-start-genetics","image":{"available_sizes":[[[107,75],"assets/images/resized/0010/1463/101463v1-max-150x150.png"],[[107,75],"assets/images/resized/0010/1463/101463v1-max-250x250.png"],[[107,75],"assets/images/resized/0010/1463/101463v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2012/06/igenica-raises-33m-series-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Igenica Raises $33M in Series C Funding","raised_amount":33000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":12,"company":{"name":"Igenica","permalink":"igenica","image":{"available_sizes":[[[150,65],"assets/images/resized/0009/0611/90611v1-max-150x150.jpg"],[[250,109],"assets/images/resized/0009/0611/90611v1-max-250x250.jpg"],[[265,116],"assets/images/resized/0009/0611/90611v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://pevc.dowjones.com/article?an=DJFVW00020120628e86sn2lt4&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120628e86sn2lt4%26from%3dalert%26pid%3d32","source_description":"Sonendo Raises $9.2M of $20M Round for Root-Canal Tool ","raised_amount":9200000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":28,"company":{"name":"Sonendo","permalink":"sonendo","image":{"available_sizes":[[[150,26],"assets/images/resized/0019/7999/197999v1-max-150x150.jpg"],[[250,44],"assets/images/resized/0019/7999/197999v1-max-250x250.jpg"],[[450,79],"assets/images/resized/0019/7999/197999v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2012/08/intercept-pharmaceuticals-completes-30m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Intercept Pharmaceuticals Completes $30M Series C Financing","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":8,"funded_day":10,"company":{"name":"Intercept Pharmaceuticals","permalink":"intercept-pharmaceuticals","image":{"available_sizes":[[[150,25],"assets/images/resized/0007/4841/74841v1-max-150x150.jpg"],[[250,42],"assets/images/resized/0007/4841/74841v1-max-250x250.jpg"],[[365,62],"assets/images/resized/0007/4841/74841v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2012/08/ornim-raises-20m-series-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Ornim Raises $20M in Series B Funding","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":8,"funded_day":21,"company":{"name":"Ornim Medical","permalink":"ornim-medical","image":{"available_sizes":[[[150,81],"assets/images/resized/0020/7345/207345v1-max-150x150.jpg"],[[165,90],"assets/images/resized/0020/7345/207345v1-max-250x250.jpg"],[[165,90],"assets/images/resized/0020/7345/207345v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://pevc.dowjones.com/article?an=DJFVW00020120823e88nlfedm&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120823e88nlfedm%26from%3dalert%26pid%3d32","source_description":" Whale Imaging Lands $8M First Round Led by OrbiMed Asia ","raised_amount":8000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":8,"funded_day":23,"company":{"name":"Whale Imaging","permalink":"whale-imaging","image":{"available_sizes":[[[150,79],"assets/images/resized/0020/7875/207875v1-max-150x150.png"],[[188,100],"assets/images/resized/0020/7875/207875v1-max-250x250.png"],[[188,100],"assets/images/resized/0020/7875/207875v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2012/08/omniguide-closes-35m-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"OmniGuide Closes $35M Financing","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":8,"funded_day":28,"company":{"name":"OmniGuide","permalink":"omniguide","image":{"available_sizes":[[[150,60],"assets/images/resized/0003/2093/32093v1-max-150x150.png"],[[187,76],"assets/images/resized/0003/2093/32093v1-max-250x250.png"],[[187,76],"assets/images/resized/0003/2093/32093v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.prnewswire.com/news-releases/aragon-pharmaceuticals-raises-50-million-in-series-d-financing-to-advance-promising-therapeutic-candidates-for-hormone-driven-cancers-172635221.html","source_description":"Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers","raised_amount":50000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":4,"company":{"name":"Aragon Pharmaceuticals","permalink":"aragon-pharmaceuticals","image":{"available_sizes":[[[150,43],"assets/images/resized/0004/9225/49225v2-max-150x150.jpg"],[[226,66],"assets/images/resized/0004/9225/49225v2-max-250x250.jpg"],[[226,66],"assets/images/resized/0004/9225/49225v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.bizjournals.com/sacramento/prnewswire/press_releases/California/2012/10/29/NY01747","source_description":"Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team","raised_amount":12500000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":29,"company":{"name":"Principia BioPharma","permalink":"principia-biopharma","image":{"available_sizes":[[[150,31],"assets/images/resized/0021/7842/217842v1-max-150x150.jpg"],[[250,52],"assets/images/resized/0021/7842/217842v1-max-250x250.jpg"],[[394,82],"assets/images/resized/0021/7842/217842v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://finance.yahoo.com/news/ambit-biosciences-completes-50-million-130000590.html","source_description":"Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia","raised_amount":50000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":11,"funded_day":6,"company":{"name":"Ambit Biosciences","permalink":"ambit-biosciences","image":{"available_sizes":[[[95,108],"assets/images/resized/0013/8681/138681v1-max-150x150.png"],[[95,108],"assets/images/resized/0013/8681/138681v1-max-250x250.png"],[[95,108],"assets/images/resized/0013/8681/138681v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.cardioxyl.com/news_events/archived_press_releases/cardioxyl_pr111312","source_description":"Cardioxyl Pharmaceuticals Raises $28 Million in Series B Financing Led by OrbiMed Advisors","raised_amount":28000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":11,"funded_day":13,"company":{"name":"Cardioxyl Pharmaceuticals","permalink":"cardioxyl-pharmaceuticals","image":{"available_sizes":[[[150,43],"assets/images/resized/0010/8066/108066v1-max-150x150.png"],[[206,60],"assets/images/resized/0010/8066/108066v1-max-250x250.png"],[[206,60],"assets/images/resized/0010/8066/108066v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://pevc.dowjones.com/article?an=DJFVW00020121129e8btrqtbz&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020121129e8btrqtbz%26from%3dalert%26pid%3d32","source_description":" CardiAQ Raises $37.3M Series B Led by OrbiMed ","raised_amount":37300000,"raised_currency_code":"USD","funded_year":2012,"funded_month":11,"funded_day":29,"company":{"name":"CardiAQ Valve Technologies","permalink":"cardiaq","image":{"available_sizes":[[[150,83],"assets/images/resized/0006/0537/60537v1-max-150x150.jpg"],[[250,139],"assets/images/resized/0006/0537/60537v1-max-250x250.jpg"],[[343,192],"assets/images/resized/0006/0537/60537v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[{"name":"Fourth health care venture fund","funded_year":2010,"funded_month":1,"funded_day":5,"raised_amount":312000000,"raised_currency_code":"USD","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32&aid=DJFVW00020100105e615000b6&r=Rss&s=DJFVW","source_description":"OrbiMed Advisors Raises $312M Toward New Venture Fund  "},{"name":"Biotech fund","funded_year":2011,"funded_month":4,"funded_day":6,"raised_amount":203000000,"raised_currency_code":"USD","source_url":"http://www.globes.co.il/serveen/globes/docview.asp?did=1000636826&fid=1725","source_description":"Gov't, Orbimed launch biomed fund"},{"name":"Health-Care royalties fund I","funded_year":2011,"funded_month":8,"funded_day":31,"raised_amount":600000000,"raised_currency_code":"USD","source_url":"http://www.fiercebiotech.com/story/orbimed-launches-600m-fund-royalty-debt-deals/2011-08-31?utm_medium=rss&utm_source=rss","source_description":"OrbiMed launches $600M fund for royalty, debt deals"},{"name":"Israeli biomedical fund","funded_year":2012,"funded_month":4,"funded_day":4,"raised_amount":222000000,"raised_currency_code":"USD","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29&aid=DJFVLS0020120404e844u90r5&r=Rss&s=DJFVLS","source_description":"OrbiMed Closes First Israel Fund At $222M, Makes Investment "}],"video_embeds":[],"external_links":[]}